American Herbal Products Association (AHPA) > News > Latest News

Former FDA official calls for new regulatory framework for dietary supplements

Editor's Note: Former FDA official Joshua Sharfstein is calling for a new regulatory framework for dietary supplements. In an article published in Drug Testing and Analysis, Sharfstein and his co-author, Akshay Kapoor, allege that the regulation of dietary supplements has not kept up with changes and risks in the market, which has ultimately led to policy gridlock. He proposes a conceptual shift from 'benefit versus risk' to 'access with safety,' which includes registration of all dietary supplements, a disclaimer on the limited role of FDA in evaluating product claims, standardized laboratory techniques, and clearer authority for the agency when safety concerns arise.

AHPA kombucha education program supports industry compliance

Kombucha experts provide guidance and resources

AHPA presented three webinars as part of its recently launched kombucha education program aimed at encouraging and supporting compliance with kombucha manufacturing, labeling, and sales regulations

Kombucha: Tax, labeling and legislation

Presented: November 4, 2015

The third in a series of kombucha webinars provides regulatory and technical guidance to the kombucha industry from several industry legal experts.

Cannabinoids for Medical Use: A Systematic Review and Meta-analysis (JAMA)

Editor's Note: This review and analysis of cannabinoids for medical use found moderate-quality evidence to support the use of cannabinoids for the treatment of chronic pain and spasticity. There was low-quality evidence suggesting that cannabinoids were associated with improvements in nausea and vomiting due to chemotherapy, weight gain in HIV, sleep disorders, and Tourette syndrome. Cannabinoids were associated with an increased risk of short-term adverse events.

NIH Office of Dietary Supplements seeks comments on Dietary Supplement Label Database

Color additive regulations expand the permitted use of spirulina extract (Federal Register)

Editor's Note: The FDA has confirmed the effective date as September 22, 2015, for the Final Rule that amended the color additive regulations to expand the permitted use of spirulina extract as a color additive to include use in coating formulations applied to dietary supplement and drug tablets and capsules. FDA received no objections or requests for a hearing on the final rule. 

AHPA joins coalition opposing proposed revision to Prop 65 lead safe harbor

OEHHA proposal is problematic from both a policy and scientific standpoint

AHPA joined a coalition to express concerns about OEHHA's proposed revisions to the Proposition 65 safe harbor Maximum Allowable Dose Levels (MADLs) for lead

GNC issues response to Oregon AG lawsuit (GNC)

Editor's Note: GNC issued the statement below noting that the lawsuit filed by the Oregon Attorney General is "without merit" and that the company will "defend itself vigorously against this unfair action."

Major victory for California marijuana dispensary in federal court

Editor's Note: A federal judge in California ruled on Oct. 19 that Congressional law defunding the Justice Department's war on medical marijuana means what it was intended to mean, that the war on medical cannabis is over. Judge Breyer ruled, "the plain reading of [Congressional law] forbids the Department of Justice from enforcing this injunction against [Marin Alliance for Medical Marijuana (MAMM)] to the extent that MAMM operates in compliance with state California law." The medical cannabis industry in California and beyond has faced a federal crackdown since 2011, with dispensaries such as Harborside Health Center and Berkeley Patients Group both facing federal forfeiture actions. The judge's order lifting an injunction against the MAMM may have far reaching legal impact for the industry, according to attorneys.

AHPA Provides Perspective on Emergency Room Visits Purportedly Associated with Supplements

When placed into context, study demonstrates relative safety of supplements

Article published in New England Journal of Medicine

overstates emergency room (ER) visits associated with dietary supplements. Study also shows supplements are relatively safe compared to other product categories.

First 10111213141516171819 Last

2018 Annual Fund Sponsors


AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.